Insider Transactions in Q4 2024 at Intra Cellular Therapies, Inc. (ITCI)
Insider Transaction List (Q4 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 31
2024
|
Rory B Riggs |
BUY
Grant, award, or other acquisition
|
Direct |
215
+0.16%
|
$17,845
$83.52 P/Share
|
|
Dec 05
2024
|
Sharon Mates Chairman and CEO |
SELL
Open market or private sale
|
Direct |
51,697
-2.31%
|
$4,342,548
$84.38 P/Share
|
|
Dec 05
2024
|
Sharon Mates Chairman and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
51,697
+4.4%
|
$620,364
$12.73 P/Share
|
|
Dec 04
2024
|
Sharon Mates Chairman and CEO |
SELL
Open market or private sale
|
Direct |
51,000
-2.3%
|
$4,335,000
$85.81 P/Share
|
|
Dec 04
2024
|
Sharon Mates Chairman and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
51,000
+4.35%
|
$612,000
$12.73 P/Share
|
|
Nov 13
2024
|
Michael Halstead President |
SELL
Open market or private sale
|
Direct |
18,714
-85.72%
|
$1,646,832
$88.54 P/Share
|
|
Nov 13
2024
|
Michael Halstead President |
BUY
Exercise of conversion of derivative security
|
Direct |
18,714
+50.0%
|
$673,704
$36.89 P/Share
|
|
Nov 12
2024
|
Michael Halstead President |
SELL
Open market or private sale
|
Direct |
22,869
-81.61%
|
$2,035,341
$89.75 P/Share
|
|
Nov 12
2024
|
Michael Halstead President |
BUY
Exercise of conversion of derivative security
|
Direct |
22,869
+50.0%
|
$525,987
$23.94 P/Share
|